REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2012

Dec 17, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2012-12-14

Reporting Person: VAGELOS P ROY (Director, Chairman of the Board)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-14	Non-Qualified Stock Option (right to buy)	$179.13	A	150000.0	Acquired	2022-12-14	Common Stock (150000.0)	Direct

Footnotes

F1: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

F2: Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.